PAREXEL International Corporation (PRXL)
|
46.08
-0.11 (-0.24%)
|
|
|
|
PRXL additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
PRXL Profile
•
Exchange
NASDAQ
•
Top Holders (By Fund)
Stratton Small-Cap Value
Wells Fargo Advantage Common Stock Inv
Wells Fargo Advantage Common Stock C
Wells Fargo Advantage Common Stock B
Wells Fargo Advantage Common Stock A
Wells Fargo Advantage Small Cap Opp Adm
Hartford Small Company I
Hartford Small Company R4
Hartford Small Company Y
Hartford Small Company R5
Wells Fargo Advantage Common Stock Inv
Wells Fargo Advantage Common Stock C
Wells Fargo Advantage Common Stock B
Wells Fargo Advantage Common Stock A
Wells Fargo Advantage Small Cap Opp Adm
Hartford Small Company I
Hartford Small Company R4
Hartford Small Company Y
Hartford Small Company R5
•
Top Holders (By Family)
•
Executives
Mr. Josef H. von Rickenbach
Founder
Chairman and Chief Exec. Officer
Dr. Mark A. Goldberg M.D.
Pres and Chief Operating Officer
Mr. James F. Winschel Jr.
Chief Financial Officer
Principal Accounting Officer Sr. VP and Treasurer
Dr. Ulf I. Schneider Ph.D.
Chief Admin. Officer and Sr. VP
Mr. Christopher J. Lindop
Director
Chairman of Audit & Fin. Committee Member of Nominating & Corp. Governance Committee Chief Financial Officer of Haemonetics Corp. and VP of Bus. Devel. - Haemonetics Corp.
Founder
Chairman and Chief Exec. Officer
Dr. Mark A. Goldberg M.D.
Pres and Chief Operating Officer
Mr. James F. Winschel Jr.
Chief Financial Officer
Principal Accounting Officer Sr. VP and Treasurer
Dr. Ulf I. Schneider Ph.D.
Chief Admin. Officer and Sr. VP
Mr. Christopher J. Lindop
Director
Chairman of Audit & Fin. Committee Member of Nominating & Corp. Governance Committee Chief Financial Officer of Haemonetics Corp. and VP of Bus. Devel. - Haemonetics Corp.
•
Employee Count
12,695
Special Offers
Competitors
| Ticker | Last trade | Change/%change | P/E ratio | |
|---|---|---|---|---|
| CVD | 76.67 | +0.15 / +0.20% | 39.57 |
PRXL earnings
Date
Actual
Expected
Prev Yr Qtr
10/30/2012
0.29
0.29
0.20
8/8/2012
0.34
0.29
0.10
4/30/2012
0.33
0.31
0.27
